Platelets in Thrombosis and Atherosclerosis A Double-Edged Sword

被引:7
作者
Bravo, Gabriela Martinez [1 ]
Annarapu, Gowtham [5 ]
Carmona, Emely [6 ]
Nawarskas, James [2 ]
Clark, Ross [3 ,4 ]
Novelli, Enrico [5 ,6 ]
Alvidrez, Roberto I. Mota [1 ,2 ,4 ]
机构
[1] Univ New Mexico, Biomed Engn Dept, Albuquerque, NM USA
[2] Univ New Mexico, Pharmaceut Sci Pharm Practice, Albuquerque, NM USA
[3] Univ New Mexico, Coll Pharm Cell Biol & Physiol, Albuquerque, NM USA
[4] Univ New Mexico, Clin & Translat Sci Ctr, Albuquerque, NM USA
[5] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh, PA USA
关键词
ACUTE CORONARY SYNDROMES; VON-WILLEBRAND-FACTOR; TISSUE FACTOR; P-SELECTIN; INFLAMMATION; MECHANISMS; RECEPTOR; INHIBITION; HEMOSTASIS; DISEASE;
D O I
10.1016/j.ajpath.2024.05.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This review focuses on the dual role of platelets in atherosclerosis and thrombosis, exploring their involvement in inflammation, angiogenesis, and plaque formation, as well as their hemostatic and pro- thrombotic functions. Beyond their thrombotic functions, platelets engage in complex interactions with diverse cell types, influencing disease resolution and progression. The contribution of platelet degranulation helps in the formation of atheromatous plaque, whereas the reciprocal interaction with monocytes adds complexity. Alterations in platelet membrane receptors and signaling cascades contribute to advanced atherosclerosis, culminating in atherothrombotic events. Understanding these multifaceted roles of platelets will lead to the development of targeted antiplatelet strategies for effective cardiovascular disease prevention and treatment. Understanding platelet functions in atherosclerosis and atherothrombosis at different stages of disease will be critical for designing targeted treatments and medications to prevent or cure the disease Through this understanding, platelets can be targeted at specific times in the atherosclerosis process, possibly preventing the development of atherothrombosis.
引用
收藏
页码:1608 / 1621
页数:14
相关论文
共 110 条
  • [1] Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin
    Abdollahi, M
    Chan, TS
    Subrahmanyam, V
    O'Brien, PJ
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 252 (1-2) : 205 - 211
  • [2] Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques
    Asada, Yujiro
    Yamashita, Atsushi
    Sato, Yuichiro
    Hatakeyama, Kinta
    [J]. PATHOLOGY INTERNATIONAL, 2020, 70 (06) : 309 - 322
  • [3] Aspirin
    Awtry, EH
    Loscalzo, J
    [J]. CIRCULATION, 2000, 101 (10) : 1206 - 1218
  • [4] Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis
    Barrett, Tessa J.
    Schlegel, Martin
    Zhou, Felix
    Gorenchtein, Mike
    Bolstorff, Jennifer
    Moore, Kathryn J.
    Fisher, Edward A.
    Berger, Jeffrey S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (517)
  • [5] Mechanisms of Plaque Formation and Rupture
    Bentzon, Jacob Fog
    Otsuka, Fumiyuki
    Virmani, Renu
    Falk, Erling
    [J]. CIRCULATION RESEARCH, 2014, 114 (12) : 1852 - 1866
  • [6] Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity-Receptors and Signalling Mechanisms
    Berger, Martin
    Naseem, Khalid M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [7] Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
    Boilard, Eric
    Nigrovic, Peter A.
    Larabee, Katherine
    Watts, Gerald F. M.
    Coblyn, Jonathan S.
    Weinblatt, Michael E.
    Massarotti, Elena M.
    Remold-O'Donnell, Eileen
    Farndale, Richard W.
    Ware, Jerry
    Lee, David M.
    [J]. SCIENCE, 2010, 327 (5965) : 580 - 583
  • [8] A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
    Brandt, John T.
    Payne, Christopher D.
    Wiviott, Stephen D.
    Weerakkody, Govinda
    Farid, Nagy A.
    Small, David S.
    Jaknbowski, Joseph A.
    Naganuma, Hideo
    Winters, Kenneth J.
    [J]. AMERICAN HEART JOURNAL, 2007, 153 (01) : 66.e9 - 66.e16
  • [9] Of von Willebrand factor and platelets
    Bryckaert, Marijke
    Rosa, Jean-Philippe
    Denis, Cecile V.
    Lenting, Peter J.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (02) : 307 - 326
  • [10] Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
    Capodanno, Davide
    Milluzzo, Rocco P.
    Angiolillo, Dominick J.
    [J]. THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2019, 13